BAX is expected to report earnings to fall 12.97% to 50 cents per share on April 24
Q1'25
Est.
$0.50
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.02
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.04
The last earnings report on February 20 showed earnings per share of 57 cents, beating the estimate of 51 cents. With 7.26M shares outstanding, the current market capitalization sits at 21.77B.
a provider of a portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices